Dr. Sánchez Vela is studying clonal hematopoiesis in the immune cells from solid tumors to identify the key genomic elements driving anti-tumoral responses.
Impact of Clonal Hematopoiesis on the Myeloid Gene Regulatory Networks that Modulate Cancer Evolution and Response to Therapy
Momentum Fellow (2020-Present)
Pablo Sánchez Vela, MD, Memorial Sloan Kettering Cancer Center